These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36007560)

  • 21. On the role of salt formation and structural similarity of co-formers in co-amorphous drug delivery systems.
    Wu W; Löbmann K; Rades T; Grohganz H
    Int J Pharm; 2018 Jan; 535(1-2):86-94. PubMed ID: 29102703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-Amorphous Formulations of Furosemide with Arginine and P-Glycoprotein Inhibitor Drugs.
    Ruponen M; Kettunen K; Santiago Pires M; Laitinen R
    Pharmaceutics; 2021 Jan; 13(2):. PubMed ID: 33514009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of co-amorphous carvedilol-maleic acid system prepared by solvent evaporation.
    Furuishi T; Sato-Hata N; Fukuzawa K; Yonemochi E
    Pharm Dev Technol; 2023; 28(3-4):309-317. PubMed ID: 36946594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cocrystals, Salts, and Salt-Solvates of olanzapine; selection of coformers and improved solubility.
    Gong W; Mondal PK; Ahmadi S; Wu Y; Rohani S
    Int J Pharm; 2021 Oct; 608():121063. PubMed ID: 34481007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nucleotides as new co-formers in co-amorphous systems: Enhanced dissolution rate, water solubility and physical stability.
    Liu X; Shen L; Zhou L; Wu W; Liang G; Zhao Y; Wu W
    Eur J Pharm Biopharm; 2024 Jul; 200():114333. PubMed ID: 38768766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New Saccharin Salt of Chlordiazepoxide: Structural and Physicochemical Examination.
    Lech A; Garbacz P; Sikorski A; Gazda M; Wesolowski M
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-Amorphous Formation of High-Dose Zwitterionic Compounds with Amino Acids To Improve Solubility and Enable Parenteral Delivery.
    Zhu S; Gao H; Babu S; Garad S
    Mol Pharm; 2018 Jan; 15(1):97-107. PubMed ID: 29164901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-amorphous palbociclib-organic acid systems with increased dissolution rate, enhanced physical stability and equivalent biosafety.
    Zhang M; Xiong X; Suo Z; Hou Q; Gan N; Tang P; Ding X; Li H
    RSC Adv; 2019 Jan; 9(7):3946-3955. PubMed ID: 35518078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downstream Processing of Amorphous and Co-Amorphous Olanzapine Powder Blends.
    da Costa NF; Daniels R; Fernandes AI; Pinto JF
    Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 35893791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Novel Desloratadine-Benzoic Acid Co-Amorphous Solid: Preparation, Characterization, and Stability Evaluation.
    Ainurofiq A; Mauludin R; Mudhakir D; Soewandhi SN
    Pharmaceutics; 2018 Jul; 10(3):. PubMed ID: 29986403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential application of low molecular weight excipients for amorphization and dissolution enhancement of carvedilol.
    Pešić N; Dapčević A; Ivković B; Kachrimanis K; Mitrić M; Ibrić S; Medarević D
    Int J Pharm; 2021 Oct; 608():121033. PubMed ID: 34419592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indomethacin co-amorphous drug-drug systems with improved solubility, supersaturation, dissolution rate and physical stability.
    Fael H; Demirel AL
    Int J Pharm; 2021 May; 600():120448. PubMed ID: 33675920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation and characterization of co-amorphous Ritonavir-Indomethacin systems by solvent evaporation technique: improved dissolution behavior and physical stability without evidence of intermolecular interactions.
    Dengale SJ; Ranjan OP; Hussen SS; Krishna BS; Musmade PB; Gautham Shenoy G; Bhat K
    Eur J Pharm Sci; 2014 Oct; 62():57-64. PubMed ID: 24878386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and characterization of amorphous ciprofloxacin-amino acid salts.
    Mesallati H; Conroy D; Hudson S; Tajber L
    Eur J Pharm Biopharm; 2017 Dec; 121():73-89. PubMed ID: 28919470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dipeptides as co-formers in co-amorphous systems.
    Wu W; Löbmann K; Schnitzkewitz J; Knuhtsen A; Pedersen DS; Rades T; Grohganz H
    Eur J Pharm Biopharm; 2019 Jan; 134():68-76. PubMed ID: 30468836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanochemical Approach to Obtaining a Multicomponent Fisetin Delivery System Improving Its Solubility and Biological Activity.
    Rosiak N; Tykarska E; Cielecka-Piontek J
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amino acids as co-amorphous excipients for simvastatin and glibenclamide: physical properties and stability.
    Laitinen R; Löbmann K; Grohganz H; Strachan C; Rades T
    Mol Pharm; 2014 Jul; 11(7):2381-9. PubMed ID: 24852326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmaceutical Salts of Carvedilol: Polymorphism and Physicochemical Properties.
    Hiendrawan S; Widjojokusumo E; Veriansyah B; Tjandrawinata RR
    AAPS PharmSciTech; 2017 May; 18(4):1417-1425. PubMed ID: 27600325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bulk, surface properties and water uptake mechanisms of salt/acid amorphous composite systems.
    Bianco S; Tewes F; Tajber L; Caron V; Corrigan OI; Healy AM
    Int J Pharm; 2013 Nov; 456(1):143-52. PubMed ID: 23948137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clozapine-carboxylic acid plasticized co-amorphous dispersions: Preparation, characterization and solution stability evaluation.
    Ali AM; Ali AA; Maghrabi IA
    Acta Pharm; 2015 Jun; 65(2):133-46. PubMed ID: 26011930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.